ストックスクリーナーアプリを入手
24.84
1.33%
-0.33
前日終値:
$25.17
開ける：
$25.36
24時間の取引高:
32,229
Relative Volume:
0.63
時価総額：
$227.82M
収益：
$103.14M
当期純損益:
$-5.82M
株価収益率:
-5.7069
EPS:
-4.3526
ネットキャッシュフロー:
$2.14M
1週間 パフォーマンス:
+5.28%
1か月 パフォーマンス:
+10.67%
6か月 パフォーマンス:
+1.82%
1年 パフォーマンス:
-14.86%
1日の値動き範囲:
$24.00
$25.93
1週間の範囲:
$23.50
$25.93
52週間の値動き範囲:
$16.05
$35.95
Sanara Medtech Inc Stock (SMTI) Company Profile
Compare SMTI vs ISRG, BDX, MDLN, ALC, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
24.86 | 230.66M | 103.14M | -5.82M | 2.14M | -4.3526 |
ISRG
Intuitive Surgical Inc
|
426.16 | 153.29B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
157.25 | 42.86B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
42.97 | 36.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.13 | 33.32B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
218.84 | 31.68B | 5.54B | 1.52B | 1.74B | 10.37 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-15 | 開始されました | Lake Street | Buy |
| 2025-03-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2024-12-23 | 開始されました | H.C. Wainwright | Buy |
| 2022-05-20 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-06-30 | 開始されました | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc (SMTI) 最新ニュース
Sanara MedTech Inc outlines its wound care focus. Longer-term growth story draws investor interest - AD HOC NEWS
Price to sales forward of Sanara MedTech Inc. – BOATS:SMTI - TradingView
Price to book forward of Sanara MedTech Inc. – NASDAQ:SMTI - TradingView
Sanara MedTech, Inc. (SMTI) Investigation: Bronstein, Gewirtz & G - The National Law Review
Sanara MedTech (SMTI) Surges 2.35% as Bulls Test Resistance at $26.08Change of Character - dars.gov.et
How Sanara Medtech Inc. (SMTI) Affects Rotational Strategy Timing - Stock Traders Daily
Sanara MedTech, Inc. Actuals & Estimates (NASDAQ:SMTI) - TradingView
SMTI Forecast — Price Target — Prediction for 2027 - TradingView
Sanara Medtech Inc (SMTI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Sanara MedTech (SMTI) Stock Gets Fair Value Bump As Analysts Back Wound Care Growth - Yahoo Finance
Sanara Medtech Inc (SMTI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Sanara Medtech Inc (SMTI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Sanara Medtech Inc (SMTI) Institutional Confidence - TradingKey
Sanara Medtech Inc (SMTI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sanara Medtech Inc (SMTI) Valuation: PE, PB & Fair Value Analysis - TradingKey
SMTI Initiates Coverage by Freedom Broker -- Rating Set to Buy - GuruFocus
Freedom Broker initiates Sanara MedTech stock with buy rating, $35 target - Investing.com UK
(SMTI) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Sanara Medtech Inc (SMTI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sanara Medtech Inc (SMTI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sanara Medtech Inc (SMTI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sanara MedTech (SMTI) Rallies 3.68% as Shares Approach Resistance ZoneDollar Neutral Pair - dars.gov.et
Sanara MedTech (SMTI) Slips 3.2% as Stock Tests Key Support LevelsDark Pool Sentiment - newsline.com
Sanara MedTech Inc. (SMTI) Tops Q3 Earnings Estimates - MSN
Sanara MedTech Shareholders Reaffirm Board and Governance Policies - TipRanks
Sanara MedTech (SMTI) investors approve board, auditor and 3-year say-on-pay cycle - Stock Titan
Responsive Playbooks and the SMTI Inflection - Stock Traders Daily
[Form 4] Sanara MedTech Inc. Insider Trading Activity - Stock Titan
Sanara MedTech (SMTI) director receives 4,154 restricted shares, total holdings 26,858 - Stock Titan
Sanara MedTech (SMTI) director awarded 5,308 restricted shares vesting in 2027 - Stock Titan
Sanara MedTech (SMTI) director granted 4,616 restricted stock shares under 2024 plan - Stock Titan
Sanara MedTech Ends Catalyst Advisory Deal, Refocuses Strategy - TipRanks
Sanara Medtech Terminates Services Agreement With Catalyst Effective June 2 - TradingView
Sanara MedTech Ends Advisory Services Agreement With The Catalyst Group Amid Strategy Shift - TradingView
Sanara MedTech (NASDAQ: SMTI) terminates Catalyst advisory agreement - Stock Titan
Sanara MedTech (SMTI) Q1 2026 Earnings Transcript - AOL.com
Sanara MedTech (SMTI) Q1 2026 Earnings Transcript - The Motley Fool
SMTI Stock Price, Quote & Chart | SANARA MEDTECH INC (NASDAQ:SMTI) - ChartMill
Sanara MedTech Inc. (SMTI) Slides as Support Test Looms; Medtech Sector Sentiment WeighsIchimoku Entry - The Legal Advocate
Sanara MedTech (SMTI) Falls 4.2% as Selling Pressure Intensifies Near SupportEarnings Beat Stocks - dars.gov.et
Sanara MedTech (SMTI) Gains 1.75% as Stock Tests Key Resistance LevelGEX Level - newsline.com
Sanara MedTech (SMTI) Q4 2025 Earnings Transcript - AOL.com
Understanding the Setup: (SMTI) and Scalable Risk - Stock Traders Daily
SMTISanara MedTech Inc Stock Price and Quote - Finviz
Sanara MedTech Dips After Swing to Profit - Bez Kabli
Sanara MedTech (SMTI) Edges Lower Amid Modest Trading, Holds Above Key SupportMarket Leader Picks - The Legal Advocate
Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc. (SMTI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
How The Sanara MedTech (SMTI) Narrative Is Shifting As The US$34 Target Stays Put - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTech Inc. (SMTI) And Encourages Shareholders to Connect - ACCESS Newswire
Sanara MedTech (SMTI) Q1 2026 Earnings: EPS $0.05 Beats EstimatesReturn On Equity - The Legal Advocate
Sanara MedTech (SMTI) Q1 2026 Earnings Beat: Revenue $N/A, EPS $0.05Viral Trade Signals - Newser
Sanara Medtech Inc (SMTI) 財務データ
収益
当期純利益
現金流量
EPS
2.39%
2.44%
大文字化:
|
ボリューム (24 時間):